GENI
Genius Sports Limited Technology - Sports Data Investor Relations →
Genius Sports Limited (GENI) closed at $4.53 as of 2026-03-20, trading 35.0% below its 200-week moving average of $6.97. This places GENI in the extreme value zone. The stock is currently moving closer to the line, down from -23.4% last week. With a 14-week RSI of 7, GENI is in oversold territory.
Over the past 14 weeks, down-weeks have had more trading volume than up-weeks (0.55 buyers-vs-sellers ratio). That means when people are active, they're more often selling than buying. Sellers are still more in control than buyers.
Over the past 236 weeks of data, GENI has crossed below its 200-week moving average 2 times. On average, these episodes lasted 82 weeks. The average one-year return after crossing below was -70.2%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1165 million, GENI is a small-cap stock. The company generates a free cash flow yield of 9.2%, which is notably high. Return on equity stands at -17.2%. The stock trades at 1.5x book value.
Share count has increased 19.7% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 4.6 years, a hypothetical investment of $100 in GENI would have grown to $25, compared to $161 for the S&P 500. GENI has returned -26.3% annualized vs 11.0% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: GENI vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After GENI Crosses Below the Line?
Across 1 historical episodes, buying GENI when it crossed below its 200-week moving average produced an average return of -41.0% after 12 months (median -41.0%), compared to -9.0% for the S&P 500 over the same periods. After 24 months, the average return was -32.0% vs +3.0% for the index.
Each line shows $100 invested at the moment GENI crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
GENI has crossed below its 200-week MA 2 times with an average 1-year return of +-70.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Nov 2021 | Nov 2024 | 157 | 80.8% | -70.2% | -71.6% |
| Feb 2026 | Ongoing | 7+ | 35.0% | Ongoing | -25.6% |
| Average | 82 | — | +-70.2% | — |
Frequently Asked Questions
Is GENI below its 200-week moving average?
Yes. As of 2026-03-20, Genius Sports Limited (GENI) is trading 35.0% below its 200-week moving average of $6.97. The current price is $4.53.
What is GENI's 200-week moving average price?
Genius Sports Limited's 200-week moving average is $6.97 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when GENI drops below its 200-week moving average?
GENI has crossed below its 200-week moving average 2 times in our data. The average one-year return after these crossings was -70.2%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 82 weeks on average.
Is GENI a good value right now?
Here's what our data says about GENI as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 7 (oversold). Free cash flow yield is 9.2%. Return on equity is -17.2%. Price-to-book is 1.5x. This is not a buy or sell recommendation — always do your own research.
How does GENI compare to the S&P 500?
Over the past 4.6 years, $100 invested in GENI would have grown to $25, compared to $161 for the S&P 500. That's -26.3% annualized vs 11.0% for the index. GENI has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20